Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

Cited by (1,003)

Items 601–700 of 1,003

1. Immunology of COVID ‐19
   Harald Brüssow · 2020 · Environmental Microbiology
2. Anti–SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study
   Evangelos Terpos, Marianna Politou, Theodoros Ν. Sergentanis, Andreas F. Mentis, Margherita Rosati, Dimitris Stellas, Jenifer Bear, Xintao Hu, Barbara K. Felber, Vasiliki Pappa et al. · 2020 · Microorganisms
3. Comparison of SARS-CoV-2 IgM and IgG seroconversion profiles among hospitalized patients in two US cities
   Erika P. Orner, Mary A. Rodgers, Karl G. Hock, Mei San Tang, Russell E. Taylor, Mary Gardiner, Olivo Ana, Amy Sue Fox, John C. Prostko, Gavin Cloherty et al. · 2020 · Diagnostic Microbiology and Infectious Disease
4. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays
   Georg Semmler, Marianna Theresia Traugott, Marianne Graninger, Wolfgang Hoepler, Tamara Seitz, Hasan Kelani, Mario Karolyi, Erich Pawelka, Sara Aragón de La Cruz, Elisabeth Puchhammer‐Stöckl et al. · 2021 · Journal of Clinical Microbiology
5. Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study
   Mar Masiá, Marta Fernández‐González, Guillermo Telenti, Vanesa Agulló, José Alberto García, Sergio Padilla, Javier García‐Abellán, Antonio Galiana, Nieves Gonzalo-Jiménez, Félix Gutiérrez · 2021 · Journal of Autoimmunity
6. Novel approaches for rapid detection of COVID-19 during the pandemic: A review
   Hoda Ilkhani, Nader Hedayat, Siamak Farhad · 2021 · Analytical Biochemistry
7. Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response
   Adrian Matthew Shields, Sian Elizabeth Faustini, Marisol Pérez-Toledo, Siân E. Jossi, Joel D. Allen, Saly Al‐Taei, Claire Backhouse, Lynsey Dunbar, Daniel Ebanks, Beena Emmanuel et al. · 2021 · BMJ Open Respiratory Research
8. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak
   Huaqing Shu, Shuzhen Wang, Shunan Ruan, Yaxin Wang, Jiancheng Zhang, Yin Yuan, Hong Liu, Yongran Wu, Ruiting Li, Shangwen Pan et al. · 2020 · Virologica Sinica
9. Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics
   Vijay Kumar · 2020 · International Immunopharmacology
10. Ultrasensitive Measurement of Both SARS-CoV-2 RNA and Antibodies from Saliva
    Dmitry Ter‐Ovanesyan, Tal Gilboa, Roey Lazarovits, Alexandra Rosenthal, Xu G. Yu, Jonathan Z. Li, George McDonald Church, David R. Walt · 2021 · Analytical Chemistry
11. Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay
    Chin-Shern Lau, See Ping Hoo, S F Yew, Siew Kim Ong, L.T.C. Lum, P.Y. Heng, Jeffrey Tan, M S Wong, Tar Choon Aw · 2020 · The Journal of Applied Laboratory Medicine
12. Characteristics and roles of severe acute respiratory syndrome coronavirus 2-specific antibodies in patients with different severities of coronavirus 19
    Zhifeng Huang, H Chen, Mingshan Xue, Huimin Huang, Peiyan Zheng, Wenting Luo, Xue Liang, Baoqing Sun, Nanshan Zhong · 2020 · Clinical & Experimental Immunology
13. A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay
    Rahul Batra, Luis Gonzalez Olivieri, Rubin Delfin, Ana S. Vallari, Sandra Pearce, Ana Olivo, John C. Prostko, Gaia Nebbia, Sam T Douthwaite, Mary A. Rodgers et al. · 2020 · Journal of Clinical Virology
14. EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19
    Alessia Alunno, Aurélie Najm, Pedro Machado, Heidi Bertheussen, Gerd Rüdiger Burmester, Francesco Carubbi, Gabriele De Marco, Roberto Giacomelli, Olivier Hermine, John Dudley Isaacs et al. · 2021 · Annals of the Rheumatic Diseases
15. Optic Neuritis in a Patient with Seropositive Myelin Oligodendrocyte Glycoprotein Antibody During the Post-COVID-19 Period
    Lepsa D. Zoric, Isidora Rajović-Mrkić, Emina Čolak, Dijana J. Miric, Bojana Kisić · 2021 · International Medical Case Reports Journal
16. Immunogenicity of BNT162b2, BBIBP-CorV and Gam-COVID-Vac vaccines and immunity after natural SARS-CoV-2 infection—A comparative study from Novi Sad, Serbia
    Vladimir Petrović, Vladimir Vuković, Aleksandra Patić, Miloš Marković, Mioljub Ristić · 2022 · PLoS ONE
17. Convalescent plasma for people with COVID-19: a living systematic review
    Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, Sarah J Valk, Catherine Kimber, Ina Monsef, Erica M. Wood, Abigail Lamikanra, David J. Roberts, Zoe McQuilten et al. · 2023 · Cochrane Database of Systematic Reviews
18. COVID-19 and Advanced Practice Registered Nurses: Frontline Update
    Ana Dı́ez-Sampedro, Arturo González, Victoria Delgado, Monica Flowers, Tatayana Maltseva, Maria Olenick · 2020 · The Journal for Nurse Practitioners
19. Closing the serological gap in the diagnostic testing for COVID‐19: The value of anti‐SARS‐CoV‐2 IgA antibodies
    Maria Giaele Infantino, Mariangela Manfredi, Valentina Grossi, Barbara Lari, Sergio Fabbri, Maurizio Benucci, Alberto Fortini, Arianna Damiani, Emanuela Maria Mobilia, Marta Panciroli et al. · 2020 · Journal of Medical Virology
20. Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?
    Ligong Lu, Hui Zhang, Meixiao Zhan, Jun Jiang, Hua Yin, Danielle J. Dauphars, Shi-You Li, Yong Li, You-Wen He · 2020 · Science China Life Sciences
21. Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections
    Carlo Perricone, Paola Triggianese, Roberto Bursi, Giacomo Cafaro, Elena Bartoloni, Maria Sole Chimenti, Roberto Gerli, Roberto Perricone · 2021 · Microorganisms
22. Convolutional neural network model based on radiological images to support COVID-19 diagnosis: Evaluating database biases
    Caio Bezerra Souto Maior, João Mateus Santana, Isis Didier Lins, Márcio J. C. Moura · 2021 · PLoS ONE
23. SARS-CoV-2-induced humoral immunity through B cell epitope analysis in COVID-19 infected individuals
    Shota Yoshida, Chikako Ono, Hiroki Hayashi, Shinya Fukumoto, Satoshi Shiraishi, Kazunori Tomono, Hisashi Arase, Yoshiharu Matsuura, Hironori Nakagami A · 2021 · Scientific Reports
24. Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9
    Tøri Vigeland Lerum, Niklas Maltzahn, Pål Aukrust, Marius Trøseid, Katerina Nezvalova Henriksen, Trine Kåsine, Anne Ma Dyrhol‐Riise, Birgitte Stiksrud, Mette Haugli, Bjørn Blomberg et al. · 2021 · Scientific Reports
25. Temporal changes in immune blood cell parameters in COVID‐19 infection and recovery from severe infection
    Christina Y. C. Yip, Eng Soo Yap, Sanjay De Mel, Winnie Z.Y. Teo, Chun‐Tsu Lee, Sheryl Kan, Melvin C.C. Lee, Will N. H. Loh, Er Luen Lim, Shir Ying Lee · 2020 · British Journal of Haematology
26. Immunotherapy for SARS-CoV-2: potential opportunities
    Mehrnoosh Pashaei, Nima Rezaei · 2020 · Expert Opinion on Biological Therapy
27. On the genetics and immunopathogenesis of COVID-19
    Chaim O. Jacob · 2020 · Clinical Immunology
28. High-dimensional single-cell analysis reveals the immune characteristics of COVID-19
    Wen Shi, Xiuxing Liu, Qiqi Cao, Pengjuan Ma, Wenqing Le, Lihui Xie, Jinguo Ye, Wen Wen, Hao Tang, Wenru Su et al. · 2020 · American Journal of Physiology-Lung Cellular and Molecular Physiology
29. Comparison of six commercially available SARS-CoV-2 antibody assays—Choice of assay depends on intended use
    Anna Christine Nilsson, Dorte Kinggaard Holm, Ulrik Stenz Justesen, Thøger Gorm-Jensen, Nanna Skaarup Andersen, Anne Lindebo Holm Øvrehus, Işık Somuncu Johansen, Jens Michelsen, Ulrik Sprogøe, Søren Thue Lillevang · 2020 · International Journal of Infectious Diseases
30. Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals
    Salma N. Younes, Hadeel T. Al-Jighefee, Farah M. Shurrab, Duaa W. Al‐Sadeq, Nadin Younes, Soha Roger Dargham, Nader Izz Eddin Al-Dewik, Hamda Abdulla Qotba, Mohamed Ahmed Syed, Ahmed Sameer Alnuaimi et al. · 2021 · Microorganisms
31. The role of estradiol in the immune response against COVID-19
    Adrián Ramírez-de-Arellano, Jorge Gutiérrez‐Franco, Erick Sierra Díaz, Ana Laura Pereira-Suárez · 2021 · HORMONES
32. Dynamic Characteristic Analysis of Antibodies in Patients With COVID-19: A 13-Month Study
    Danrong Shi, Tian-Hao Weng, Jie Wu, Chunyan Dai, Rui Luo, Keda Chen, Miaojin Zhu, Xiangyun Lu, Linfang Cheng, Qiuqiang Chen et al. · 2021 · Frontiers in Immunology
33. Differential chromatin accessibility in peripheral blood mononuclear cells underlies COVID-19 disease severity prior to seroconversion
    Nicholas S. Giroux, Shengli Ding, Micah T. McClain, Thomas W. Burke, Elizabeth Petzold, Hong A. Chung, Grecia O. Rivera, Ergang Wang, Rui Xi, Shree Bose et al. · 2022 · Scientific Reports
34. Nucleic Acid Testing for Coronavirus Disease 2019: Demand, Research Progression, and Perspective
    Shiyin Zhang, Xiaosong Su, Jin Wang, Mengyuan Chen, Caiyu Li, Tingdong Li, Shengxiang Ge, Ningshao Xia · 2020 · Critical Reviews in Analytical Chemistry
35. Positive aspects, negative aspects and limitations of plasma therapy with special reference to COVID-19
    Basavraj Nagoba, Ajay M Gavkare, Nawab P. Jamadar, Sachin S Mumbre, Sohan P Selkar · 2020 · Journal of Infection and Public Health
36. Structural basis for the inhibition of SARS-CoV2 main protease by Indian medicinal plant-derived antiviral compounds
    Konda Mani Saravanan, Haiping Zhang, Renganathan Senthil, Kevin Kumar Vijayakumar, Vignesh Sounderrajan, Yanjie Wei, Harshavardhan Shakila · 2020 · Journal of Biomolecular Structure and Dynamics
37. IgA2 Antibodies against SARS-CoV-2 Correlate with NET Formation and Fatal Outcome in Severely Diseased COVID-19 Patients
    Léonie A. N. Staats, Hella Pfeiffer, Jasmin Knopf, Aylin Lindemann, Julia Fürst, Andreas Emanuel Kremer, Holger Hackstein, Markus Friedrich Neurath, Luis Enrique Munoz, Susanne Achenbach et al. · 2020 · Cells
38. Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients
    Yanan Wang, Jingjing Li, Huijun Li, Ping Lei, Guanxin Shen, Chunguang Yang · 2020 · International Immunopharmacology
39. Antibody (IgA, IgG, and IgG Subtype) Responses to SARS-CoV-2 in Severe and Nonsevere COVID-19 Patients
    Harshad P. Patil, Prajakta S. Rane, Shubham Shrivastava, Sonali Hemant Palkar, Sanjay Kewalchand Lalwani, Akhilesh Chandra Mishra, Vidya Avinash Arankalle · 2021 · Viral Immunology
40. Age-dependent seroprevalence of SARS-CoV-2 antibodies in school-aged children from areas with low and high community transmission
    Lise Boey, Mathieu Roelants, Joanna Merckx, Niel Hens, Isabelle Desombere, Els Duysburgh, Corinne Vandermeulen · 2021 · European Journal of Pediatrics
41. Comparison of SARS-CoV-2 Antibody Responses and Seroconversion in COVID-19 Patients Using Twelve Commercial Immunoassays
    Sojeong Yun, Ji Hyeong Ryu, Joo Hee Jang, Hyunjoo Bae, Seung-Hyo Yoo, Ae‐Ran Choi, Sung Jin Jo, Jihyang Lim, Jehoon Lee, Hyejin Ryu et al. · 2021 · Annals of Laboratory Medicine
42. Evaluation of a Surrogate Enzyme-Linked Immunosorbent Assay–Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation With Immunoglobulin G Commercial Serology Assays
    Vijayalakshmi Nandakumar, Tracie Profaizer, Bucky K. Lozier, Marc Elgort, Erin T. Larragoite, Elizabeth S. C. P. Williams, Antonio Solis‐Leal, Joel Lopez, Bradford K. Berges, Vicente Planelles et al. · 2021 · Archives of Pathology & Laboratory Medicine
43. Duration of SARS-CoV-2 sero-positivity in a large longitudinal sero-surveillance cohort: the COVID-19 Community Research Partnership
    David M. Herrington, John W. Sanders, Thomas F. Wierzba, Martha A. Alexander‐Miller, Mark Andrew Espeland, Alain Gerald Bertoni, Allison Mathews, Austin Lyles Seals, Iqra Munawar, Michael S. Runyon et al. · 2021 · BMC Infectious Diseases
44. The difference between IgM and IgG antibody prevalence in different serological assays for COVID-19; lessons from the examination of healthcare workers
    Yurie Kobashi, Yuzo Shimazu, Yoshitaka Nishikawa, Takeshi Kawamura, Tatsuhiko Kodama, Daiji Obara, Masaharu Tsubokura · 2020 · International Immunopharmacology
45. IgG and IgM antibody formation to spike and nucleocapsid proteins in COVID-19 characterized by multiplex immunoblot assays
    Jyotsna Shah, Song Liu, Hari-Hara S. K. Potula, Prerna Bhargava, Iris Du Cruz, Denise Force, Ammar Bazerbashi, Ranjan Ramasamy · 2021 · BMC Infectious Diseases
46. Quantitative SARS-CoV-2 Spike Antibody Response in COVID-19 Patients Using Three Fully Automated Immunoassays and a Surrogate Virus Neutralization Test
    Yoonjoo Kim, Ji Hyun Lee, Geon Young Ko, Ji Hyeong Ryu, Joo Hee Jang, Hyunjoo Bae, Seung-Hyo Yoo, Ae‐Ran Choi, Jin Hwan Jung, Jong Min Lee et al. · 2021 · Diagnostics
47. Covid-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients?
    Jean Amiral, Anne Marie Vissac, Jerard Seghatchian · 2020 · Transfusion and Apheresis Science
48. Serological tests for COVID‐19: Potential opportunities
    Marcarious Moorkereh Tantuoyir, Nima Rezaei · 2020 · Cell Biology International
49. The comprehensive clinic, laboratory, and instrumental evaluation of children with COVID‐19: A 6‐months prospective study
    Sara Isoldi, Saverio Mallardo, Alessia Marcellino, Silvia Bloise, Anna Dilillo, Donatella Iorfida, Alessia Testa, Emanuela Del Giudice, Vanessa Martucci, Mariateresa Sanseviero et al. · 2021 · Journal of Medical Virology
50. Evaluation of Antibody Response in Symptomatic and Asymptomatic COVID-19 Patients and Diagnostic Assessment of New IgM/IgG ELISA Kits
    Hadeel T. Al-Jighefee, Hadi Mohamad Yassine, Maryam Ali Al‐Nesf, Ali Ait Hssain, Sara Taleb, Ahmed S. Mohamed, Hassen Maatoug, Mohamed Gaafar Hussein Mohamedali, Gheyath K. Nasrallah · 2021 · Pathogens
51. Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects
    Angela Huynh, Donald M. Arnold, James W. Smith, Jane C. Moore, Ali Zhang, Zain Chagla, Bart J. Harvey, Hannah D. Stacey, Jann Catherine Ang, Rumi Clare et al. · 2021 · Viruses
52. Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide
    Luca Bollo, Tommaso Guerra, Davide Fiore Bavaro, Laura Monno, Annalisa Saracino, Gioacchino Angarano, Damiano Paolicelli, María Trojano, Pietro Iaffaldano · 2020 · Journal of the Neurological Sciences
53. Transcriptomic analysis of COVID‑19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection
    Eugenio Cavalli, Maria Cristina Petralia, Maria Sofia Basile, Alessia Bramanti, Placido Bramanti, Ferdinando Nicoletti, Demetrios A. Spandidos, Yehuda Shoenfeld, Paolo Fagone · 2020 · International Journal of Molecular Medicine
54. Analytical and Clinical Evaluation of the Automated Elecsys Anti–SARS-CoV-2 Antibody Assay on the Roche cobas e602 Analyzer
    Clarence W. Chan, Kyle Parker, Vera Tešić, Angel D Baldwin, Nga Yeung Tang, Xander M.R. van Wijk, Kiang-Teck J Yeo · 2020 · American Journal of Clinical Pathology
55. Update on serologic testing in COVID–19
    Rafal G. Krajewski, Justyna Gołębiowska, Sebastian Makuch, Grzegorz J. Mazur, Siddarth Agrawal · 2020 · Clinica Chimica Acta
56. SARS-CoV-2 Infection in One Cat and Three Dogs Living in COVID-19-Positive Households in Madrid, Spain
    Guadalupe Miró, Javier Regidor‐Cerrillo, Rocío Checa, Carlos Diezma‐Díaz, Ana Montoya, Jesús García‐Cantalejo, Pedro Botías, Javier Arroyo, Luis Miguel Ortega‐Mora · 2021 · Frontiers in Veterinary Science
57. The role of SARS-CoV-2 N protein in diagnosis and vaccination in the context of emerging variants: present status and prospects
    Wanchen Song, Zhongbiao Fang, Feike Ma, Jiaxuan Li, Zhiwei Huang, Yanjun Zhang, Jianhua Li, Keda Chen · 2023 · Frontiers in Microbiology
58. Potential diagnostics and therapeutic approaches in COVID-19
    Pratibha Kumari, Archana Kumari Singh, Moses Rinchui Ngasainao, Ilma Shakeel, Sanjay Kumar, Seema Lal, Anchal Singhal, Sukhwinder Singh Sohal, Indrakant Kumar Singh, Md. Imtaiyaz Hassan · 2020 · Clinica Chimica Acta
59. Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2
    Dennis Lapuente, Clara Maier, Pascal Irrgang, Julian Hübner, Antonia Sophia Peter, Markus Hoffmann, Armin Ensser, Katharina Ziegler, Thomas Winkler, Torsten Birkholz et al. · 2020 · European Journal of Clinical Microbiology & Infectious Diseases
60. The bumpy road to achieve herd immunity in COVID-19
    Monica Teodora Neagu · 2020 · Journal of Immunoassay and Immunochemistry
61. SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments
    Gisela Canedo-Marroquín, Farides Saavedra, Catalina A. Andrade, Roslye V. Berríos-Rojas, Linmar Rodríguez‐Guilarte, María Cecilia Opazo, Claudia A. Riedel, Alexis M. Kalergis · 2020 · Frontiers in Immunology
62. The COVID-19 vaccine development: A pandemic paradigm
    Diego de Carvalho Carneiro, Jéssica de Oliveira Sousa, Joana Paixão Monteiro-Cunha · 2021 · Virus Research
63. Immune response to SARS-CoV-2 variants: A focus on severity, susceptibility, and preexisting immunity
    Eman A. Alefishat, Herbert Franz Jelinek, Mira Mousa, Guan K. Tay, Habiba S. AlSafar · 2022 · Journal of Infection and Public Health
64. ADE and hyperinflammation in SARS-CoV2 infection- comparison with dengue hemorrhagic fever and feline infectious peritonitis
    Maryse Cloutier, Madhuparna Nandi, Awais Ullah Ihsan, Hugues Allard‐Chamard, Subburaj Ilangumaran, Sheela Ramanathan · 2020 · Cytokine
65. Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection
    Puya Dehgani‐Mobaraki, Asiya Kamber Zaidi, Nidhi Yadav, A. Floridi, Emanuela Floridi · 2021 · Clinical Immunology
66. The global concern of food security during the COVID-19 pandemic: Impacts and perspectives on food security
    Xuecheng Zhu, Xinyue Yuan, Ying Zhang, Huilin Liu, Jing Wang, Baoguo Sun · 2021 · Food Chemistry
67. COVID and Lung Cancer
    Luana Calabrò, Giulia Rossi, Alessia Covre, Aldo Morra, Michele Maio · 2021 · Current Oncology Reports
68. Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review
    Areez Shafqat, Shameel Shafqat, Sulaiman Alsalameh, Junaid Kashir, Khaled Manae AlKattan, Ahmed Yaqinuddin · 2022 · Frontiers in Immunology
69. Long period dynamics of viral load and antibodies for SARS-CoV-2 infection: an observational cohort study
    Jianping Huang, Tingting Mao, Shufei Li, Lianpeng Wu, Xueqin Xu, Huanzheng Li, Chenyang Xu, Feifei Su, Jianyi Dai, Jichan Shi et al. · 2020 · medRxiv
70. Severe Acute Respiratory Syndrome Coronavirus 2: From Gene Structure to Pathogenic Mechanisms and Potential Therapy
    Jun Wu, Xiaohui Yuan, Bing Wang, Rui Gu, Wei Li, Xuemei Xiang, Lijun Tang, Hongyu Sun · 2020 · Frontiers in Microbiology
71. SARS-CoV-2 IgG antibody responses in New York City
    Josh Reifer, Nosson Hayum, Benzion Heszkel, Ikey Klagsbald, Vincent A. Streva · 2020 · Diagnostic Microbiology and Infectious Disease
72. Intervalo de tempo decorrido entre o início dos sintomas e a realização do exame para COVID-19 nas capitais brasileiras, agosto de 2020*
    Francisca Elisângela Teixeira Lima, Nila Larisse Silva de Albuquerque, Sabrina de Souza Gurgel Florencio, Maria Gabriela Miranda Fontenele, Ana Paula Oliveira Queiroz, Glaubervania Alves Lima, Lanese Medeiros de Figueiredo, Silvia Maria Costa Amorim, Lorena Pinheiro Barbosa · 2020 · Epidemiologia e Serviços de Saúde
73. Fatty-Acid-Binding Proteins: From Lipid Transporters to Disease Biomarkers
    Shabarni Gaffar, A Sayyidatina Aathirah · 2023 · Biomolecules
74. Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies
    Aurélie Velay, Floriane Gallais, Iliès Benotmane, Marie-Josée Wendling, François Danion, Olivier Collange, Jerome De Seze, Catherine Schmidt‐Mutter, Francis Schneider, Pascal Bilbault et al. · 2020 · Diagnostic Microbiology and Infectious Disease
75. Recommendations for the Diagnosis, Prevention, and Control of Coronavirus Disease-19 in Children—The Chinese Perspectives
    Fang Feng, Yu Chen, Dongchi Zhao, Liu Tonglin, Yongjian Huang, Liru Qiu, Yan Hao, Xiaolin Hu, Wei Yin, Zhisheng Liu et al. · 2020 · Frontiers in Pediatrics
76. COVID-19 Impact on Diagnostic Innovations: Emerging Trends and Implications
    Anne O. Oyewole, Lucy Barrass, Emily G. Robertson, James Woltmann, Hannah O’Keefe, Harsimran Sarpal, Kim Dangova, Catherine Richmond, Dawn Craig · 2021 · Diagnostics
77. Salivette, a relevant saliva sampling device for SARS-CoV-2 detection
    Monique Melo Costa, Nicolas Benoît, Jérôme Dormoi, Rémy Amalvict, Nicolas Gomez, Hervé Tissot‐Dupont, Matthieu Million, Bruno Pradines, Samuel Granjeaud, Lionel Alméras · 2021 · Journal of Oral Microbiology
78. A Multiplex and Colorimetric Reverse Transcription Loop-Mediated Isothermal Amplification Assay for Sensitive and Rapid Detection of Novel SARS-CoV-2
    Eduardo Juscamayta‐López, Faviola Valdivia, Helen Horna, David D. Tarazona, Liza Linares, Nancy Rojas, Maribel Huaringa · 2021 · Frontiers in Cellular and Infection Microbiology
79. Cross-reactive antibodies elicited to conserved epitopes on SARS-CoV-2 spike protein after infection and vaccination
    Eric S. Geanes, Cas LeMaster, Elizabeth Fraley, Santosh Khanal, Rebecca McLennan, Elin Grundberg, Rangaraj Selvarangan, Todd Bradley · 2022 · Scientific Reports
80. Return to work guidelines for the COVID-19 pandemic
    Juan Carlos Rueda-Garrido, Ma Teófila Vicente-Herrero, Mª Teresa del Campo, Luis Reinoso Barbero, Rafael E. de la Hoz, George L. Delclos, Stefanos N. Kales, Alejandro Fernández‐Montero · 2020 · Occupational Medicine
81. COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity
    Marie Kroemer, Laurie Spehner, Lucie Vettoretti, Adeline Bouard, Guillaume Eberst, Sébastien Pili‐Floury, Gilles Capellier, Quentin Lepiller, Émeline Orillard, Laura Mansi et al. · 2020 · Journal of Infection
82. High seroprevalence of SARS-CoV-2 in elderly care employees in Sweden
    Johanna Frida Lindahl, Tove Hoffman, Mouna Esmaeilzadeh, Björn Olsén, Reidar Winter, Stefan Amér, Christian Molnár, Ann Svalberg, Åke Lundkvist · 2020 · Infection Ecology & Epidemiology
83. Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) infection
    Pei Hua Lee, Woo Chiao Tay, Stephanie Sutjipto, Siew‐Wai Fong, Sean Wei Xiang Ong, Wycliff Enli Wei, Yi‐Hao Chan, Li Min Ling, Barnaby Edward Young, Matthias Paul HS Toh et al. · 2020 · Clinical & Translational Immunology
84. Comparative Clinical Evaluation of the Roche Elecsys and Abbott Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Serology Assays for Coronavirus Disease 2019 (COVID-19)
    Shaun Shi Yan Tan, Sharon Saw, Ka Lip Chew, Cindy Wang, Anastacia Pajarillaga, Candy Khoo, Weixuan Wang, Zahidah Mohamed Ali, Zhixin Yang, Yiong Huak Chan et al. · 2020 · Archives of Pathology & Laboratory Medicine
85. What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19?
    Enrico De Lorenzis, Gerlando Natalello, Laura Gigante, Lucrezia Verardi, Silvia Laura Bosello, Elisa Gremese · 2020 · Autoimmunity Reviews
86. Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies
    Hadi Mohamad Yassine, Hadeel T. Al-Jighefee, Duaa W. Al‐Sadeq, Soha Roger Dargham, Salma N. Younes, Farah M. Shurrab, Reham M. Marei, Ali Ait Hssain, Sara Taleb, Hashim Alhussain et al. · 2020 · International Journal of Infectious Diseases
87. Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2
    N. Taefehshokr, Sina Taefehshokr, B. Heit · 2020 · Pathogens
88. Point-of-care test system for detection of immunoglobulin-G and -M against nucleocapsid protein and spike glycoprotein of SARS-CoV-2
    Tao Peng, Zhiwei Sui, Zhenghui Huang, Jie Xie, Kai Wen, Yongzhuo Zhang, Wenfeng Huang, Wei Mi, Ke Peng, Xinhua Dai et al. · 2021 · Sensors and Actuators B Chemical
89. Sera neutralizing activities against SARS-CoV-2 and multiple variants six month after hospitalization for COVID-19
    M. Betton, M. Livrozet, D. Planas, A. Fayol, Blandine Monel, B. Vedie, T. Bruel, E. Tartour, Nicolas Robillard, J. Manuguerra et al. · 2021 · Clinical Infectious Diseases
90. The role of antigen-presenting cells in the pathogenesis of COVID-19
    Rana Farzi, Parisa Shiri Aghbash, Narges Eslami, Arezou Azadi, Ali Shamekh, Nima Hemmat, Taher Entezari‐Maleki, Hossein Bannazadeh Baghi · 2022 · Pathology - Research and Practice
91. Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients
    Jira Chansaenroj, Ritthideach Yorsaeng, Jiratchaya Puenpa, Nasamon Wanlapakorn, Chintana Chirathaworn, Natthinee Sudhinaraset, Manit Sripramote, Piti Chalongviriyalert, Supunee Jirajariyavej, Phatharaporn Kiatpanabhikul et al. · 2022 · PLoS ONE
92. Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection
    B. Escudero-Pérez, P. Lawrence, J. Castillo-Olivares · 2023 · Frontiers in Immunology
93. Laboratory Tests for COVID-19: A Review of Peer-Reviewed Publications and Implications for Clinical Use.
    Daniel Shyu, James Dorroh, Caleb Holtmeyer, Detlef G. Ritter, Anandhi Upendran, Raghuraman Kannan, Dima Dandachi, Christian Rojas‐Moreno, Stevan P. Whitt, Hariharan Regunath · 2020 · PubMed Central
94. Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands
    Maria Skaalum Petersen, Marin Strøm, Debes Hammershaimb Christiansen, Jógvan Páll Fjallsbak, Eina Hansen Eliasen, Malan Johansen, Anna Sofía Veyhe, Marnar Fríðheim Kristiansen, Shahin Gaïni, Lars Fodgaard Møller et al. · 2020 · Emerging infectious diseases
95. Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses
    Patrick O’Connell, Yasser Ali Aldhamen · 2020 · Human Vaccines & Immunotherapeutics
96. An Original ELISA-Based Multiplex Method for the Simultaneous Detection of 5 SARS-CoV-2 IgG Antibodies Directed against Different Antigens
    Constant Gillot, Jonathan Douxfils, Julie Cadrobbi, Kim Laffineur, Jean‐Michel Dogné, Marc Elsen, Christine Eucher, Sabrina Melchionda, Élise Modaffari, Marie Tré‐Hardy et al. · 2020 · Journal of Clinical Medicine
97. What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021
    Jin‐Hong Yoo · 2021 · Journal of Korean Medical Science
98. A review on the immune responses against novel emerging coronavirus (SARS-CoV-2)
    Ramin Lotfi, Rasoul Nasiri Kalmarzi, Seyed Askar Roghani · 2021 · Immunologic Research
99. Applications of laboratory findings in the prevention, diagnosis, treatment, and monitoring of COVID-19
    Zirui Meng, Shuo Guo, Yanbing Zhou, Mengjiao Li, Minjin Wang, Binwu Ying · 2021 · Signal Transduction and Targeted Therapy
100. Biological and Psychological Factors Determining Neuropsychiatric Outcomes in COVID-19
     Boris Tizenberg, Lisa A. Brenner, Christopher A. Lowry, Olaoluwa O. Okusaga, David R. Benavides, Andrew J. Hoisington, Michael E. Benros, John W. Stiller, Ronald C. Kessler, Teodor T. Postolache · 2021 · Current Psychiatry Reports